Sh Fosun Pharma traded at 26.25 this Monday February 2nd, decreasing 0.42 or 1.57 percent since the previous trading session. Looking back, over the last four weeks, Sh Fosun Pharma lost 3.74 percent. Over the last 12 months, its price rose by 9.47 percent. Looking ahead, we forecast Sh Fosun Pharma to be priced at 26.08 by the end of this quarter and at 24.40 in one year, according to Trading Economics global macro models projections and analysts expectations.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products are mainly applied in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood system, anti-tumor and anti-infection diseases. The Company is also engaged in medical equipment and medical diagnosis business, as well as the provision of medical services. It distributes its products primarily in domestic and overseas markets.